Use of a Smartphone© Application to Study Autism Spectrum Disorders (ASD)
NCT ID: NCT03020277
Last Updated: 2024-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2018-04-03
2019-06-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Smartphone Application for Screening of Developmental Disorders in Children
NCT04958174
Early Screening of Autism Spectrum Disorder in General and Pediatric Practices
NCT04274127
Assessment of the Benefit of Teleconsultations for Children With Autism Spectrum Disorders
NCT02996708
Clinical and Neurophysiological Evolutions Through a Functional Rehabilitation of Social Communication in ASD
NCT02444117
Telepsychiatry in Children: Diagnostic Evaluation of Autism Spectrum Disorder
NCT06622395
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Population:
The investigators propose to study individuals diagnosed with ASD based on National Health Authority (HAS) recommendations (on ADI-R diagnoses) from 3-16 years of age in the Pays de la Loire region. The investigators propose to include 100 families. The study is exploratory in nature; thus, randomizing patients is unnecessary. The investigators will include the first 100 families agreeing to participate in the study and meeting the inclusion criteria. All participants will be recruited from the Department of Child and Adolescent Psychiatry of University Hospital of Nantes and from the Regional Center for Autism (CRA des Pays de la Loire).
Method:
At the inclusion visit, parents will receive a code to download the app from the "application store" of their choice (depending on their Smartphone©) and sign an informed consent form.
All type 1 data from the inclusion visit will be stored in an electronic database and in the Smartphone© application (during the setup process).
This initial evaluation by the investigator will include the following type 1 data:
* Sibling rank and marital status,
* Lifestyle: rural or urban; single or multiple occupants of the chid's bedroom and housing type and surface,
* Educational and teaching load and conditions (special education, inclusive education, partial or full time, etc.), and
* The therapeutic management (speech therapy, psychomotor therapy, etc.).
Type 2 data will be stored in the electronic database only:
* Age at diagnosis,
* Current drug treatments (name, starting date and dose),
* Comorbidities (associated epilepsy, mental retardation and organic pathology),
* Medical and psychiatric family antecedent (ATCD),
* Original scores on the Autism Diagnostic Interview-Revised (ADI-R) and Autism Diagnostic Observation Schedule (ADOS) at the time of diagnosis, and
* Scores on the French version of the Childhood Autism Rating Scale (CARS) (http://www.autisme.qc.ca) at baseline and at the end of the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ASD children families
Ecological Momentary Assessment with Smartphone© Application
Filling of the application every 3 days for 6 months by subjects (parents of patients with ASD)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ecological Momentary Assessment with Smartphone© Application
Filling of the application every 3 days for 6 months by subjects (parents of patients with ASD)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having at least one Smartphone© (iOS Apple or Android).
* Signing the consent form for participation.
Exclusion Criteria
* Having children living in more than two areas
3 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de Recherche en Santé Publique, France
OTHER
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier Bonnot, PU-PH
Role: PRINCIPAL_INVESTIGATOR
Nantes CHU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Angers CHU
Angers, , France
Nantes CHU
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bonnot O, Bonneau D, Doudard A, Duverger P. Rationale and protocol for using a smartphone application to study autism spectrum disorders: SMARTAUTISM. BMJ Open. 2016 Nov 22;6(11):e012135. doi: 10.1136/bmjopen-2016-012135.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC16_0185
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.